Clin2
NCT06071208Likely a fitNot yet recruiting

Preventing Kidney Disease in Egyptians with Diabetes

Diabetes Mellitus Without Complication

Part of Hormones & metabolism, Kidney & urinary clinical trials.

This study aims to find ways to prevent kidney disease in people with diabetes or prediabetes. It may help protect your kidneys and keep them healthy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have diabetes or prediabetes

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05749679Not yet recruiting
Prevent kidney failure in people with long-term type 2 diabetes

This study aims to prevent worsening kidney function in people with type 2 diabetes by closely following kidney health in everyday general practice. It may help you stay on top of kidney changes and reduce the risk of progressing to kidney failure.

NCT05715814Recruiting· Phase 3
Test diabetes-pill type medicine on kidney dialysis safety

This Phase 3 trial studies the safety of an SGLT2 inhibitor (a diabetes medication that can affect kidney fluid handling) in people on peritoneal dialysis. The goal is to see how the treatment works in your type of dialysis and whether it causes any problems.

Toronto, Ontario
NCT05345327Recruiting· Phase 3
First diabetes pill to protect kidneys

This Phase 3 trial tests whether starting a diabetes medicine called dapagliflozin can better slow kidney damage than starting metformin in adults with type 2 diabetes. It may help preserve kidney function over time and reduce future kidney decline.

Sydney, New South Wales
NCT06398977Recruiting
Dapagliflozin to protect kidney function in dialysis patients

This trial tests whether a diabetes drug called dapagliflozin can help people on peritoneal dialysis keep their remaining kidney function longer. It is for patients who started dialysis recently and still make urine.

Chengdu, Sichuan
NCT07325201Not yet recruiting· Phase 2
Preventing DKA with continuous ketone monitoring in type 1 diabetes

This study tests a dual continuous ketone and glucose monitor to help prevent diabetic ketoacidosis (DKA) in people with type 1 diabetes who are starting SGLT2 inhibitor treatment. SGLT2 inhibitors are a newer type of diabetes medicine, but they can increase the risk of DKA. The device may make using these medicines safer.

Minneapolis, Minnesota
NCT07309094Recruiting
Effects of a diabetes drug on fat tissue in kidney disease

This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can improve fat tissue health in people with chronic kidney disease who also have type 2 diabetes, cardiovascular disease, or obesity. It may help protect your kidneys and overall health.

Valencia, Valencia

Hear when a new Diabetes Mellitus Without Complication trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.